Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Ibuprofen × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Pain 1 Neoplasms 1 Mucositis 1 Inflammation 1 Head and Neck Neoplasms 1 Cachexia 1 Breast Neoplasms 1 Breast Diseases 1 Agnosia 1 Abnormalities, Radiation-Induced 1

Interventions

Radiotherapy 8 Zoledronic Acid 7 Fentanyl 7 nabiximols 6 Morphine 6 Ibandronic Acid 6 Ketamine 5 Hydromorphone 5 Analgesia 5 Acetaminophen 5 Tapentadol 4 Oxycodone 4 Acupuncture Therapy 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Duloxetine Hydrochloride 2 Docetaxel 2 Calcium 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 strontium chloride 1 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡